Vascular remodeling and endothelial dysfunction in patients with occupational chronic obstructive pulmonary disease caused by exposure to industrial aerosol nanoparticles

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: The characteristics of vascular pathology in different phenotypes of occupational chronic obstructive pulmonary disease (COPD), as well as the causal role of various industrial aerosol components, especially nanoparticles, are poorly understood.

AIM: To determine the characteristics of arterial remodeling and endothelial function in patients with occupational COPD caused by exposure to aerosol nanoparticles.

METHODS: An observational, cohort cross-sectional study was performed in patients with occupational COPD caused by exposure to aerosols containing metal (n = 48) or silicon (n = 55) nanoparticles, compared with COPD caused by tobacco smoking (n = 50). Scanning electron microscopy and inductively coupled plasma atomic emission spectroscopy were used to measure the size and chemical composition of particles, respectively. The procedures used in the study included color-flow duplex scanning of the brachiocephalic arteries, brachial arteries, and aorta; flow-mediated dilation test of the brachial arteries; and enzyme-linked immunosorbent assay of molecular markers. Linear regression was used to determine relationships.

RESULTS: The group of occupational COPD caused by aerosols with silicon nanoparticles had the highest values of carotid intima-media thickness: 1.2 [0.9; 1.5] mm; in the group of occupational COPD caused by aerosols with metal nanoparticles and the control group, these values were 0.9 [0.7; 1.0] mm and 0.8 [0.7; 0.9] mm, respectively (p = 0.009). Moreover, the group of occupational COPD caused by aerosols with silicon nanoparticles had the highest incidence of atherosclerosis compared to the group of occupational COPD caused by aerosols with metal nanoparticles and the control group (41.8% vs. 22.9% and 18.0%, respectively; р = 0.003). The aortic pulse wave velocity in the three groups was 12.6 [11.2; 14.1], 9.3 [8.9; 10.7], and 7.2 [6.9; 8.4] m/s, respectively (р = 0.001). The minimum flow-mediated dilation of the brachial arteries was 2.5 [2.1; 3.4], 3.8 [3.3; 4.6], and 4.7 [4.5; 5.3]%, respectively (р = 0.001). Occupational COPD caused by aerosols with silicon nanoparticles was associated with the highest serum levels of vascular cell adhesion molecule 1, von Willebrand factor, transforming growth factor β1, procollagen III N-terminal propeptide, and fibroblast growth factor 2. Regression relationships were found between the intima-media thickness and the concentration of metal (adjusted R-squared [R2]: 0.36) and silicon (adjusted R2: 0.47) nanoparticles, as well as the length of employment (adjusted R2: 0.27). Moreover, regression relationships were found between the flow-mediated dilation of the brachial arteries and the concentration of metal (adjusted R2: 0.51) and silicon (adjusted R2: 0.71) nanoparticles, the length of employment (adjusted R2: 0.68), and the total concentration of silicon-containing dust (adjusted R2: 0.55).

CONCLUSION: Occupational COPD caused by exposure to aerosol nanoparticles (especially silicon-containing ones) is associated with significant vascular remodeling and endothelial dysfunction, which must be considered during follow-up care.

About the authors

Lyubov A. Shpagina

Novosibirsk State Medical University

Author for correspondence.
Email: lashpagina@gmail.com
ORCID iD: 0000-0003-0871-7551
SPIN-code: 5773-6649

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Novosibirsk

Marina A. Zenkova

Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences

Email: marzen@niboch.nsc.ru
ORCID iD: 0000-0003-4044-1049
SPIN-code: 2284-2692

Dr. Sci. (Biology), Professor, Corresponding Member of the Russian Academy of Sciences

Russian Federation, Novosibirsk

Anatoly I. Saprykin

Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences

Email: saprykin@niic.nsc.ru
ORCID iD: 0000-0002-8999-8457
SPIN-code: 4688-9801

Dr. Sci. (Engineering)

Russian Federation, Novosibirsk

Evgenia B. Logashenko

Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences

Email: evg.log@gmail.com
ORCID iD: 0000-0001-8977-5395
SPIN-code: 7408-9400

Cand. Sci. (Biology)

Russian Federation, Novosibirsk

Ilya S. Shpagin

Novosibirsk State Medical University

Email: doctor_ilya@mail.ru
ORCID iD: 0000-0002-3109-9811
SPIN-code: 2892-6184

MD, Dr. Sci. (Medicine), Associate Professor

Russian Federation, Novosibirsk

Olga S. Kotova

Novosibirsk State Medical University

Email: ok526@yandex.ru
ORCID iD: 0000-0003-0724-1539
SPIN-code: 2488-0659

MD, Dr. Sci. (Medicine), Associate Professor

Russian Federation, Novosibirsk

Alfia R. Tsygankova

Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences

Email: mkb-2@yandex.ru
ORCID iD: 0000-0001-7126-276X
SPIN-code: 6619-9694

Cand. Sci. (Chemistry)

Russian Federation, Novosibirsk

Elena G. Kondyurina

Novosibirsk State Medical University

Email: econdur@yandex.ru
ORCID iD: 0000-0003-3250-3107
SPIN-code: 8665-9138

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Novosibirsk

Vera V. Zelenskaya

Novosibirsk State Medical University

Email: v.zelenskaya@mail.ru
ORCID iD: 0000-0003-0344-9412
SPIN-code: 9151-5099

MD, Dr. Sci. (Medicine), Associate Professor

Russian Federation, Novosibirsk

Galina V. Kuznetsova

Novosibirsk State Medical University

Email: doktor67@list.ru
ORCID iD: 0000-0001-7428-9159

MD, Cand. Sci. (Medicine)

Russian Federation, Novosibirsk

Ekaterina V. Anikina

Novosibirsk State Medical University

Email: mkb-2@yandex.ru
ORCID iD: 0000-0002-6047-1707
SPIN-code: 3847-0025
Russian Federation, Novosibirsk

Natalya V. Kamneva

Novosibirsk State Medical University

Email: natali.spor@yandex.ru
ORCID iD: 0000-0003-3251-0315
SPIN-code: 8868-3043

MD, Cand. Sci. (Medicine)

Russian Federation, Novosibirsk

Valery A. Sergeev

Novosibirsk State Medical University

Email: valerasergeev030197@yandex.ru
ORCID iD: 0009-0007-6984-4294
Russian Federation, Novosibirsk

Tatyana N. Surovenko

Pacific State Medical University

Email: mkb-2@yandex.ru
ORCID iD: 0000-0001-7676-3213
SPIN-code: 6169-4476

MD, Dr. Sci. (Medicine)

Russian Federation, Vladivostok

References

  1. Bystritskaya EV, Bilichenko TN. The morbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015–2019). Pulmonologiya. 2021;31(5):551–561. doi: 10.18093/0869-0189-2021-31-5-551-561 EDN: KXDQEV
  2. Drapkina OM, Kontsevaya AV, Mukaneeva DK, et al. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022. Pulmonologiya. 2022;32(4):507–516. doi: 10.18093/0869-0189-2022-32-4-507-516 EDN: MZWUQY
  3. Egorenko SN, editor. Russian Statistical Yearbook. Moscow: Rosstat; 2023.
  4. Halpin DMG, Martinez FJ. Pharmacotherapy and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;206(10):1201–1207. doi: 10.1164/rccm.202205-1000PP EDN: ICYMFU
  5. Jiang R, Sun C, Yang Y, et al. Causal relationship between chronic obstructive pulmonary disease and heart failure: A Mendelian randomization study. Heart Lung. 2024;67:12–18. doi: 10.1016/j.hrtlng.2024.04.007 EDN: YRXATG
  6. Ingebrigtsen TS, Marott JL, Vestbo J, et al. Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap. BMJ Open Respir Res. 2020;7(1):e000470. doi: 10.1136/bmjresp-2019-000470 EDN: TSOTJX
  7. Almagro P, Soler-Cataluña JJ, Huerta A, et al. Impact of comorbidities in COPD clinical control criteria. The CLAVE Study. BMC Pulm Med. 2024;24(1):6. doi: 10.1186/s12890-023-02758-0 EDN: TLJAXG
  8. Xue Z, Guo S, Liu X, et al. Impact of COPD or asthma on the risk of atrial fibrillation: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:872446. doi: 10.3389/fcvm.2022.872446 EDN: SWAPQA
  9. Løkke A, Hilberg O, Lange P, et al. Exacerbations predict severe cardiovascular events in patients with COPD and stable cardiovascular disease — a nationwide, population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2023;18:419–429. doi: 10.2147/COPD.S396790 EDN: KKVGHX
  10. Xu S, Gu Z, Zhu W, Feng S. Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction. ESC Heart Fail. 2024. doi: 10.1002/ehf2.14958 EDN: IKIZRO
  11. Shpagina LA, Kamneva NV, Shpagin IS, et al. Molecular markers in occupational chronic obstructive pulmonary disease comorbid with heart failure. Annals of the Russian Academy of Medical Sciences. 2020;75(5):541–551. doi: 10.15690/vramn1381 EDN: UARRQV
  12. Panev NI, Evseeva NA, Filimonov SN, et al. Risk factors for coronary heart disease in miners with anthracosilicosis. Russian Journal of Occupational Health and Industrial Ecology. 2021;61(3):161–167. doi: 10.31089/1026-9428-2021-61-3-161-167 EDN: WFOOKG
  13. Sorkina NS, Kuzmina LP, Artemova LV, Bezrukavnikova LM. Issues of the effects of lead on circulatory and respiratory diseases. Russian Journal of Occupational Health and Industrial Ecology. 2019;(12):983–988. doi: 10.31089/1026-9428-2019-59-12-983-988 EDN: FVGJXT
  14. Popova AYu, Onishchenko GG, Rakitskii VN. Hygiene in supporting scientific and technological development of the country and sanitary and epidemiological welfare of the population (to the 130th anniversary of the Federal Scientific Centre of Hygiene named after F.F. Erisman). Hygiene and Sanitation, Russian Journal. 2021;100(9):882–889. doi: 10.47470/0016-9900-2021-100-9-882-889 EDN: OXJKGH
  15. Shpagina LA, Zenkova MA, Saprykin AI, et al. The role of nanoparticles of industrial aerosols in the formation of occupational bronchopulmonary pathology. Russian Journal of Occupational Health and Industrial Ecology. 2024;64(2):111–120. doi: 10.31089/1026-9428-2024-64-2-111-120 EDN: DBXTZJ
  16. Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356–392. doi: 10.18093/0869-0189-2022-32-3-356-392 EDN: ANYVUN
  17. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. doi: 10.1093/eurheartj/ehx095 EDN: VFJGYP
  18. Vaes AW, De Boever P, Franssen FME, et al. Endothelial function in patients with COPD: an updated systematic review of studies using flow-mediated dilatation. Expert Rev Respir Med. 2023;17(1):53–69. doi: 10.1080/17476348.2023.2176845 EDN: XULOKC
  19. Georgiopoulos G, Mavraganis G, Delialis D, et al. Carotid ultrasonography improves residual risk stratification in guidelines-defined high cardiovascular risk patients. Eur J Prev Cardiol. 2022;29(13):1773–1784. doi: 10.1093/eurjpc/zwac095 EDN: ULONSP
  20. Malyutina NN, Yuy ND, Luzina SV, et al. Prognosis of forming phenotype of comorbidity of arterial hypertension and erosive-ulcerative lesions of gastroduodenal zone in railway transport workers. Perm Medical Journal. 2022;39(6):17–27. doi: 10.17816/pmj39617-27 EDN: ZMAHMW
  21. Mancusi C, Manzi MV, de Simone G, et al. Carotid atherosclerosis predicts blood pressure control in patients with hypertension: the Campania Salute Network Registry. J Am Heart Assoc. 2022;11(5):e022345. doi: 10.1161/JAHA.121.022345 EDN: MQPFMP
  22. Nevzorova VA, Zakharchuk NV, Shapkina EU, et al. COPD and preclinical cardiovascular disease. South Russian Journal of Therapeutic Practice. 2021;2(2):70–79. doi: 10.21886/2712-8156-2021-2-2-70-79 EDN: BIEKCD
  23. Watanabe K, Onoue A, Omori H, et al. Association between airflow limitation and carotid intima-media thickness in the Japanese population. Int J Chron Obstruct Pulmon Dis. 2021;16:715–726. doi: 10.2147/COPD.S291477 EDN: ROTOMG
  24. Zhang X, Zhang S, Huang Q, et al. Comparison of arterial stiffness and ultrasound indices in patients with and without chronic obstructive pulmonary disease. Rev Assoc Med Bras (1992). 2022;68(5):605–609. doi: 10.1590/1806-9282.2021203 EDN: JYMWCW
  25. Screm G, Mondini L, Salton F, et al. Vascular endothelial damage in COPD: where are we now, where will we go? Diagnostics (Basel). 2024;14(9):950. doi: 10.3390/diagnostics14090950 EDN: LABQLL
  26. Yu GH, Fang Y. Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway. Toxicol Appl Pharmacol. 2022;446:116047. doi: 10.1016/j.taap.2022.116047 EDN: DOLRDO

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».